annual D&A:
$97.00M+$66.10M(+213.97%)Summary
- As of today (August 29, 2025), ABCL annual depreciation & amortization is $97.00 million, with the most recent change of +$66.10 million (+213.97%) on December 31, 2024.
- During the last 3 years, ABCL annual D&A has risen by +$79.75 million (+462.31%).
- ABCL annual D&A is now at all-time high.
Performance
ABCL Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$7.31M+$704.50K(+10.67%)Summary
- As of today (August 29, 2025), ABCL quarterly depreciation & amortization is $7.31 million, with the most recent change of +$704.50 thousand (+10.67%) on June 1, 2025.
- Over the past year, ABCL quarterly D&A has dropped by -$30.41 million (-80.62%).
- ABCL quarterly D&A is now -80.91% below its all-time high of $38.29 million, reached on September 30, 2024.
Performance
ABCL quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$64.45M-$30.41M(-32.06%)Summary
- As of today (August 29, 2025), ABCL TTM depreciation & amortization is $64.45 million, with the most recent change of -$30.41 million (-32.06%) on June 1, 2025.
- Over the past year, ABCL TTM D&A has increased by +$3.78 million (+6.23%).
- ABCL TTM D&A is now -32.17% below its all-time high of $95.02 million, reached on December 31, 2024.
Performance
ABCL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABCL Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +214.0% | -80.6% | +6.2% |
| 3 y3 years | +462.3% | +21.9% | +225.2% |
| 5 y5 years | +5151.6% | +576.8% | +3634.1% |
ABCL Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +462.3% | -80.9% | +21.9% | -32.2% | +225.2% |
| 5 y | 5-year | at high | +5151.6% | -80.9% | +632.5% | -32.2% | +3634.1% |
| alltime | all time | at high | >+9999.0% | -80.9% | +1031.5% | -32.2% | +9876.9% |
ABCL Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $7.31M(+10.7%) | $64.45M(-32.1%) |
| Mar 2025 | - | $6.61M(-46.1%) | $94.86M(-0.2%) |
| Dec 2024 | $97.00M(+214.0%) | $12.25M(-68.0%) | $95.02M(+3.8%) |
| Sep 2024 | - | $38.29M(+1.5%) | $91.51M(+50.8%) |
| Jun 2024 | - | $37.72M(+457.5%) | $60.67M(+100.5%) |
| Mar 2024 | - | $6.77M(-22.6%) | $30.26M(-1.2%) |
| Dec 2023 | $30.89M(-6.7%) | $8.74M(+17.3%) | $30.61M(-15.4%) |
| Sep 2023 | - | $7.45M(+2.0%) | $36.19M(+2.8%) |
| Jun 2023 | - | $7.31M(+2.6%) | $35.20M(+3.9%) |
| Mar 2023 | - | $7.12M(-50.3%) | $33.89M(+6.8%) |
| Dec 2022 | $33.10M | $14.31M(+121.7%) | $31.74M(+42.7%) |
| Sep 2022 | - | $6.46M(+7.7%) | $22.25M(+12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $6.00M(+20.6%) | $19.82M(+9.1%) |
| Mar 2022 | - | $4.97M(+3.1%) | $18.16M(+5.9%) |
| Dec 2021 | $17.25M(+227.3%) | $4.82M(+19.9%) | $17.16M(+13.9%) |
| Sep 2021 | - | $4.02M(-7.3%) | $15.06M(+25.1%) |
| Jun 2021 | - | $4.34M(+9.5%) | $12.03M(+37.2%) |
| Mar 2021 | - | $3.97M(+45.5%) | $8.77M(+60.9%) |
| Dec 2020 | $5.27M(+185.4%) | $2.73M(+173.2%) | $5.45M(+100.1%) |
| Sep 2020 | - | $997.90K(-7.6%) | $2.72M(+57.8%) |
| Jun 2020 | - | $1.08M(+67.2%) | $1.73M(+167.2%) |
| Mar 2020 | - | $646.00K | $646.00K |
| Dec 2019 | $1.85M(+101.2%) | - | - |
| Dec 2018 | $918.00K | - | - |
FAQ
- What is AbCellera Biologics Inc. annual depreciation & amortization?
- What is the all time high annual D&A for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual D&A year-on-year change?
- What is AbCellera Biologics Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly D&A year-on-year change?
- What is AbCellera Biologics Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM D&A year-on-year change?
What is AbCellera Biologics Inc. annual depreciation & amortization?
The current annual D&A of ABCL is $97.00M
What is the all time high annual D&A for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual depreciation & amortization is $97.00M
What is AbCellera Biologics Inc. annual D&A year-on-year change?
Over the past year, ABCL annual depreciation & amortization has changed by +$66.10M (+213.97%)
What is AbCellera Biologics Inc. quarterly depreciation & amortization?
The current quarterly D&A of ABCL is $7.31M
What is the all time high quarterly D&A for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly depreciation & amortization is $38.29M
What is AbCellera Biologics Inc. quarterly D&A year-on-year change?
Over the past year, ABCL quarterly depreciation & amortization has changed by -$30.41M (-80.62%)
What is AbCellera Biologics Inc. TTM depreciation & amortization?
The current TTM D&A of ABCL is $64.45M
What is the all time high TTM D&A for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM depreciation & amortization is $95.02M
What is AbCellera Biologics Inc. TTM D&A year-on-year change?
Over the past year, ABCL TTM depreciation & amortization has changed by +$3.78M (+6.23%)